Realty Income has a solid strategy. It largely caters to companies in non-discretionary, service-oriented, non-retail, and ...

GSK's main partner in the consumer health joint venture that became Haleon – Pfizer – holds the remaining 32% in the new company and has said that it will sell its stake now that the ...

In corporate governance news, Bryan Supran, a Non-Executive Director representing Pfizer (NYSE:PFE), has stepped down from Haleon’s board following Pfizer’s reduction of its stake in the ...

Haleon HLN-2.04%decrease ... The consumer-health giant, which was spun out of GSK and is partly owned by Pfizer, said Thursday that it made a pretax profit of 1.91 billion pounds ($2.42 billion ...

Pfizer sold 700 million ordinary shares of its investment in Haleon for approximately $3.0 billion, which brings down its stake in Haleon from approximately 15% to approximately 7%. Currently ...

LONDON - Haleon PLC (LSE/NYSE: HLN), a global consumer health company, announced a change to its Board of Directors today. Following the decline of Pfizer Inc. (NYSE:PFE)’s shareholding in ...

Pfizer to sell $3 billion stake in Sensodyne maker Haleon Pfizer will sell shares worth 2.50 billion pounds ($3.05 billion) in Haleon , lowering its stake in the British consumer healthcare ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

LONDON - Haleon PLC (LSE/NYSE: LON:HLN), a global consumer health company, announced a change to its Board of Directors today. Following the decline of Pfizer Inc. (NYSE:PFE)'s shareholding in Haleon ...